Are B Cells a Potential Target for Therapeutic Intervention in the Classical T Cell-Mediated Autoimmune Disease Type 1 Diabetes?

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 8, Iss. 2, 2009-06 ,pp. : 130-138

Bentham Science Publishers

Access to resources Recommend Favorite

B cell depletion in systemic lupus erythematosus

By Leandro Maria J   Ehrenstein Michael R  

Clinical Medicine, Vol. 7, Iss. 1, 2007-01 ,pp. : 57-59

Royal College Of Physicians

Access to resources Recommend Favorite

B-Cell Based Gene Therapy for Autoimmune Diseases

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 12, Iss. 3, 2012-06 ,pp. : 241-247

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of a pectic polysaccharide from a medicinal herb, the roots of Bupleurum falcatum L. on interleukin 6 production of murine B cells and B cell lines

By Guo Y.   Matsumoto T.   Kikuchi Y.   Ikejima T.   Wang B.   Yamada H.  

Immunopharmacology, Vol. 49, Iss. 3, 2000-09 ,pp. : 307-316

Elsevier

Access to resources Recommend Favorite

Recent advances in the management of autoimmune myocarditis: insights from animal studies.

By  

Current Pharmaceutical Design, Vol. 22, Iss. 4, 2016-02 ,pp. : 427-439

Bentham Science Publishers

Access to resources Recommend Favorite